Afficher la couverture '[Allergy to neuromuscular blocking agents].. Allergie et curares | Chiriac, Anca Mirela' en grand format
/5

0 avis

[Allergy to neuromuscular blocking agents].. Allergie et curares

Archive ouverte

Chiriac, Anca Mirela | Demoly, Pascal

Edité par CCSD ; Elsevier Masson [1983-....] -

International audience. Allergy to neuromuscular blocking agents (NMBAs) has been the first cause of perioperative anaphylaxis for decades, in most countries. The most frequently involved agents are suxamethonium and rocuronium. The allergy work-up is compulsory to demonstrate or rule out allergy to NMBAs, if there is a compatible clinical history. Doing otherwise exposes the patient to death if the same or related NMBA is re-injected. In cases of true allergy, assessing cross-reactivity to other NMBAs is mandatory. The cross-sensitization hypothesis is presently being investigated and if confirmed, it could allow primary prevention measures to be implemented.

Consulter en ligne

Suggestions

Du même auteur

Médecine personnalisée et hypersensibilités médicamenteuses

Archive ouverte | Chiriac, Anca Mirela | CCSD

International audience. Personalized medicine is supposed to tailor actions of prevention and treatments to individual patient data. Personalized medicine is a challenge in the drug allergy/hypersensitivity field. I...

Drug provocation tests: up-date and novel approaches.

Archive ouverte | Chiriac, Anca Mirela | CCSD

International audience. Drug provocation tests (DPTs) are often needed when evaluating patients with suspected drug hypersensitivity reactions. General considerations on DPTs, with regard to indications, contraindic...

Are drugs more dangerous? Drug-induced anaphylaxis across the world

Archive ouverte | Chiriac, Anca Mirela | CCSD

International audience. Drug-induced anaphylaxis (DIA) is a well-recognized risk factor for virtually all classes of medications. The incidence and specific risk factors vary widely depending on the class of drug an...

Chargement des enrichissements...